LRINEC Score Calculator – Necrotizing Fasciitis Risk Assessment
Laboratory Parameters
All six laboratory values are required to calculate a complete score.
About the LRINEC Score
The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was developed to help distinguish necrotizing fasciitis from other severe soft-tissue infections using six routinely available laboratory parameters. The original score ranges from 0 to 13.
This calculator implements the original Wong et al. laboratory thresholds. Risk bands are displayed as low (0–5), intermediate (6–7), and high (8–13), consistent with commonly reproduced LRINEC stratification.
Scoring Criteria
| Parameter | Laboratory value | Points |
|---|---|---|
| CRP | <150 mg/L | 0 |
| CRP | ≥150 mg/L | 4 |
| WBC | <15 ×10⁹/L | 0 |
| WBC | 15–25 ×10⁹/L | 1 |
| WBC | >25 ×10⁹/L | 2 |
| Hemoglobin | >13.5 g/dL | 0 |
| Hemoglobin | 11–13.5 g/dL | 1 |
| Hemoglobin | <11 g/dL | 2 |
| Sodium | ≥135 mmol/L | 0 |
| Sodium | <135 mmol/L | 2 |
| Creatinine | ≤141 µmol/L | 0 |
| Creatinine | >141 µmol/L | 2 |
| Glucose | ≤10 mmol/L | 0 |
| Glucose | >10 mmol/L | 1 |
Score Interpretation
| Total score | Risk category |
|---|---|
| 0–5 | Low risk category |
| 6–7 | Intermediate risk category |
| 8–13 | High risk category |
These categories are score strata, not individualized probabilities and not a definitive diagnosis. Predictive values vary with disease prevalence, case mix, infection site, and study setting.
Evidence and Limitations
The original derivation study reported strong performance in its development and validation cohorts. Subsequent external studies and meta-analyses have shown substantially lower sensitivity in some settings.
- In a 2019 meta-analysis, LRINEC ≥6 had pooled sensitivity of 68.2% and specificity of 84.8%; LRINEC ≥8 had sensitivity of 40.8% and specificity of 94.9%.
- A prospective extremity cohort reported sensitivity of 43% at ≥6 and 27% at ≥8, with an AUROC of 0.696.
- Performance may vary by anatomical site, patient population, timing of blood sampling, comorbidities, and comparator diagnosis.
Clinical Use
Use the score only as an adjunct in adults with suspected necrotizing soft-tissue infection. The original score is not established as a pediatric rule and should not be used as a stand-alone screening, diagnostic, or exclusion test.
Severe pain out of proportion, rapidly progressive infection, systemic toxicity, edema extending beyond erythema, bullae, ecchymosis, skin necrosis, or crepitus should prompt urgent clinical evaluation. Surgical consultation should not be delayed by a low score.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.